ARTICLE | Company News
sanofi-aventis licenses Kyowa mAb
May 15, 2009 1:12 AM UTC
Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151) granted sanofi-aventis Group (Euronext:SAN; NYSE:SNY) exclusive, worldwide rights to develop and commercialize a human mAb against tumor necrosis factor ligand ...